Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating venetoclax in combination with trastuzumab emtansine in previously treated HER2-positive locally advanced or metastatic breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab emtansine (ado-trastuzumab emtansine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-11-08